Use of zinc and copper gluconate in the treatment of methicillin-resistant Staphylococcus aureus
AssigneesDantrace-Danfeed Ivs, Distributors Processing, Inc.
InventorJens Jorgen Pedersen
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of zinc and copper gluconate in the treatment of methicillin-resistant Staphylococcus aureus and dietary supplements for mammals comprising zinc and copper gluconate and their use in treatment of methicillin-resistant Staphylococcus aureus.
Claims10
A method of treatment of methicillin-resistant Staphylococcus aureus in a mammal belonging to the genus Sus of the Suidae family, the method comprising oral administration to said mammal of an animal feed comprising zinc gluconate and copper gluconate, wherein said zinc gluconate is administered in a dose of between 50 to 80 mg zinc/kg feed, and said copper gluconate is administered in a dose of between 5 to 25 mg copper/kg feed.
Dependencies are inferred from the claim text.